As lifestyle and diet structure impact our health, non-alcoholic fatty liver disease (NAFLD) is
prevalent all over the world. Some phytomedicines containing berberine (BBR) have been …

Nonalcoholic fatty liver disease (NAFLD) is a globally observed metabolic disease with high
prevalence both in adults and children. However, there is no efficient medication available …

Hepatic dysfunction is primarily caused by nonalcoholic fatty liver disease (NAFLD).
Recently, berberine (BBR) has attracted researchers' interest with its hepatic protective …

The incidence of Non-Alcoholic Fatty Liver Disease (NAFLD) has been rapidly increasing
during the last decade. It is a relevant health problem that affects 25% of the general …

Background Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent
worldwide, emerging as a significant health issue on a global scale. Berberine exhibits …

Berberine (BBR), an active ingredient from nature plants, has demonstrated multiple
biological activities and pharmacological effects in a series of metabolic diseases including …

The histological spectrum of nonalcoholic fatty liver diseases (NAFLD) ranges from hepatic
steatosis to steatohepatitis and fibrosis. Berberine (BBR) is known for its therapeutic effect …

Background Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic
manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti …

Increasing evidence demonstrates that berberine (BBR) is beneficial for obesity-associated
non-alcoholic fatty liver disease (NAFLD). However, it remains to be elucidated how BBR …

Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver
conditions, and its progression is marked by evolution to non-alcoholic steatosis …